Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 834

Showing 1-25 of 834 citing articles:

CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 307
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e229317-e229317
Open Access | Times Cited: 208
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 206
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Karen Hager, Gonzalo Pérez Marc, Philipe Gobeil, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2084-2096
Open Access | Times Cited: 183
Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection
Young‐Eun Kim, Kyungmin Huh, Young-Joon Park, et al.
JAMA (2022) Vol. 328, Iss. 9, pp. 887-887
Open Access | Times Cited: 125
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 111
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 91
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 86
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
Clauber Henrique Souza da Costa, Camila Auad Beltrão de Freitas, Cláudio Nahum Alves, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 81
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 78
Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore
M Premikha, Calvin J. Chiew, Wycliffe Enli Wei, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 8, pp. 1442-1445
Open Access | Times Cited: 74
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 55
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
Miriam Echaide, Luisa Chocarro, Ana Bocanegra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5944-5944
Open Access | Times Cited: 54
COVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
Deobrat Mallick, Lokesh Goyal, Prabal Chourasia, et al.
Cureus (2023)
Open Access | Times Cited: 43
Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis
Francesca Gioia, Laura N. Walti, Ani Orchanian‐Cheff, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 3, pp. 207-216
Closed Access | Times Cited: 25
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 2
A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein
Nimisha Ghosh, Suman Nandi, Indrajit Saha
International Immunopharmacology (2022) Vol. 105, pp. 108565-108565
Open Access | Times Cited: 61
Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
Ramy Mohamed Ghazy, Rasha Ashmawy, Noha Alaa Hamdy, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 350-350
Open Access | Times Cited: 59
The Race for Global Equitable Access to COVID-19 Vaccines
Lukman Nul Hakim Md Khairi, Mathumalar Loganathan Fahrni, Antonio Ivan Lazzarino
Vaccines (2022) Vol. 10, Iss. 8, pp. 1306-1306
Open Access | Times Cited: 59
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19
Matthew G. Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 8, pp. 1126-1134
Open Access | Times Cited: 56
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 759-759
Open Access | Times Cited: 55
Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
Fahadul Islam, Manish Dhawan, Mohamed H. Nafady, et al.
Annals of Medicine and Surgery (2022) Vol. 78
Open Access | Times Cited: 47
SARS-CoV-2 Infection and Lung Regeneration
Fuxiaonan Zhao, Qingwen Ma, Qing Yue, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top